| Filed On | Filing |
|---|---|
| 16 Nov 2026 | SCHEDULE 13G/A |
| 16 Nov 2026 | SCHEDULE 13G/A |
| 16 Nov 2026 | 10-Q |
| 13 Nov 2026 | SCHEDULE 13G/A |
| 30 Oct 2026 | 425 |
| 08 Oct 2026 | 425 |
| 24 Sep 2026 | 425 |
| 14 Sep 2026 | 425 |
| 14 Aug 2026 | 10-Q |
| 14 Aug 2026 | SCHEDULE 13G |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 12 Aug 2026 | SCHEDULE 13G/A |
| 03 Aug 2026 | 425 |
| 28 Jul 2026 | 425 |
| 27 Jul 2026 | 425 |
| 27 Jul 2026 |
8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities
Certain information marked with [***] has been excluded from this exhibit because it is not material and is the type that the registrant treats as private or confidential. |
| 16 Jul 2026 | SCHEDULE 13G/A |
| 08 Jul 2026 |
8-K: Other Events
NEW YORK, NY – July 6, 2026 – Translational Development Acquisition Company (NYSE: TDAC) ( “TDAC”) announced that ProLogium has filed their initial F-4 with the SEC driving the companies forward towards a successful execution of the de-S... |
| 29 Jun 2026 | 425 |
| 23 Jun 2026 | DEFA14A |
Loading...